Latest Commercialization News

Page 306 of 380
Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, yet highlights significant progress in carbon capture and storage and emissions reduction efforts. The company remains committed to its net-zero targets and sustainable growth strategy.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, yet the company maintains strong profitability and advances key climate initiatives including the Moomba CCS project.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights progress in carbon capture and storage and emissions reduction. The company maintains a strong balance sheet while advancing its Climate Transition Action Plan.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet the company achieved a net profit of $1.224 billion while making significant strides in carbon capture and storage and emissions reduction.
Maxwell Dee
Maxwell Dee
30 Apr 2025
EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.
Ada Torres
Ada Torres
30 Apr 2025
Ava Risk Group reported a solid Q3 FY2025 with $6.5 million in sales orders and a key new contract with Telstra for subsea cable protection, setting the stage for accelerated growth in Q4.
Sophie Babbage
Sophie Babbage
30 Apr 2025
Dotz Nano has successfully demonstrated its DotzEarth direct air capture technology at lab scale and secured a A$4 million investment to advance to real-world pilot testing, signaling growing momentum in its carbon capture ambitions.
Victor Sage
Victor Sage
30 Apr 2025
Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.
Ada Torres
Ada Torres
30 Apr 2025
Lunnon Metals Limited has showcased significant progress in its gold and nickel exploration projects, highlighting strong drilling results and development plans for the Lady Herial gold deposit and Baker-Foster nickel resources.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Mindax Limited has secured $7.75 million through a share placement and acquired strategic stakes in Doublebell Resource Wealth and Cashmere Iron, advancing its vision to develop the Mid-West region into a major iron ore hub.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Stakk Limited reports a staggering 2,533% quarter-on-quarter increase in annual recurring revenue to $472k, fueled by its acquisition of US-based Radical DBX and rapid expansion in Embedded Finance across Australia and the US.
Victor Sage
Victor Sage
30 Apr 2025
Rare Foods Australia has secured shareholder approval to voluntarily delist from the ASX, while implementing significant cost reductions and achieving record growth in its Subsea Estate wine brand.
Eva Park
Eva Park
30 Apr 2025